Literature DB >> 1645803

Antigenic stability of foot-and-mouth disease virus variants on serial passage in cell culture.

M J Gonzalez1, J C Saiz, O Laor, D M Moore.   

Abstract

Two neutralizing monoclonal antibody (MAb)-resistant variants selected from an isolate of foot-and-mouth disease virus (FMDV) type A5 were repeatedly passaged in cell culture and monitored for susceptibility to neutralization by the selecting MAb. A variant isolated with a MAb to a conformational epitope (1-OG2) lost resistance in 20 passages, while a variant isolated with a MAb to a linear epitope (1-HA6) persisted for 30 passages. In both cases, the virus population emerging after passage was antigenically and genetically indistinguishable from the original wild-type parental virus (FMDV A5 Spain-86). Coinfection assays with the wild type and each variant, and between the variants, showed rapid conversion to a homogeneous population. Wild-type virus prevailed over the variants and for coinfection between the variants, the linear epitope variant 1-HA6. While both variants arose from a single nucleotide substitution and reversion to wild type occurred for each, it appears that the variant based on the continuous epitope (1-HA6) was more stable. We discuss the implications of these results for the antigenic diversity of FMDV and its relationship to virus evolution.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1645803      PMCID: PMC241435     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants.

Authors:  J C Saiz; M J Gonzalez; M V Borca; F Sobrino; D M Moore
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

2.  RNA virus quasispecies populations can suppress vastly superior mutant progeny.

Authors:  J C de la Torre; J J Holland
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

3.  Epitope mapping of foot-and-mouth disease virus with neutralizing monoclonal antibodies.

Authors:  C Bolwell; B E Clarke; N R Parry; E J Ouldridge; F Brown; D J Rowlands
Journal:  J Gen Virol       Date:  1989-01       Impact factor: 3.891

4.  Implications of a quasispecies genome structure: effect of frequent, naturally occurring amino acid substitutions on the antigenicity of foot-and-mouth disease virus.

Authors:  M G Mateu; M A Martínez; E Rocha; D Andreu; J Parejo; E Giralt; F Sobrino; E Domingo
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

5.  Analysis of neutralizing antigenic sites on the surface of type A12 foot-and-mouth disease virus.

Authors:  B Baxt; V Vakharia; D M Moore; A J Franke; D O Morgan
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

6.  Antigenic comparison of different foot-and-mouth disease virus types using monoclonal antibodies defining multiple neutralizing epitopes on FMDV A5 subtypes.

Authors:  J C Saiz; M J Gonzalez; D O Morgan; J L Card; F Sobrino; D M Moore
Journal:  Virus Res       Date:  1989-05       Impact factor: 3.303

7.  Neutralizing epitopes of type O foot-and-mouth disease virus. I. Identification and characterization of three functionally independent, conformational sites.

Authors:  P V Barnett; E J Ouldridge; D J Rowlands; F Brown; N R Parry
Journal:  J Gen Virol       Date:  1989-06       Impact factor: 3.891

8.  Sequence analysis of monoclonal antibody resistant mutants of type O foot and mouth disease virus: evidence for the involvement of the three surface exposed capsid proteins in four antigenic sites.

Authors:  J D Kitson; D McCahon; G J Belsham
Journal:  Virology       Date:  1990-11       Impact factor: 3.616

9.  The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid).

Authors:  G Fox; N R Parry; P V Barnett; B McGinn; D J Rowlands; F Brown
Journal:  J Gen Virol       Date:  1989-03       Impact factor: 3.891

10.  Selection of antigenic variants of foot-and-mouth disease virus in the absence of antibodies, as revealed by an in situ assay.

Authors:  J Diez; M G Mateu; E Domingo
Journal:  J Gen Virol       Date:  1989-12       Impact factor: 3.891

View more
  9 in total

Review 1.  Foot-and-mouth disease.

Authors:  Marvin J Grubman; Barry Baxt
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

2.  Fitness alteration of foot-and-mouth disease virus mutants: measurement of adaptability of viral quasispecies.

Authors:  M A Martínez; C Carrillo; F González-Candelas; A Moya; E Domingo; F Sobrino
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

3.  Serial passage in tissue culture of mixed foot-and-mouth disease virus serotypes.

Authors:  E L Woodbury; A R Samuel; N J Knowles
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

4.  Oligo(A) sequences of human respiratory syncytial virus G protein gene: assessment of their genetic stability in frameshift mutants.

Authors:  B García-Barreno; T Delgado; J A Melero
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

5.  HSV type 1 genome variants from persistently productive infections in Raji and BJAB cell lines.

Authors:  S M Klauck; W Hampl; A K Kleinschmidt
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

6.  Emergence of a new strain of type O foot-and-mouth disease virus: its phylogenetic and evolutionary relationship with the PanAsia pandemic strain.

Authors:  Divakar Hemadri; Chakradhar Tosh; Aniket Sanyal; Ramamurthy Venkataramanan
Journal:  Virus Genes       Date:  2002       Impact factor: 2.332

7.  Evolution of the capsid protein genes of foot-and-mouth disease virus: antigenic variation without accumulation of amino acid substitutions over six decades.

Authors:  M A Martínez; J Dopazo; J Hernández; M G Mateu; F Sobrino; E Domingo; N J Knowles
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

Review 8.  Cell culture propagation of foot-and-mouth disease virus: adaptive amino acid substitutions in structural proteins and their functional implications.

Authors:  Veronika Dill; Michael Eschbaumer
Journal:  Virus Genes       Date:  2019-11-27       Impact factor: 2.332

9.  Attempt to Isolate Elephant Endotheliotropic Herpesvirus (EEHV) Using a Continuous Cell Culture System.

Authors:  Kornravee Photichai; Thunyamas Guntawang; Tidaratt Sittisak; Varankpicha Kochagul; Phongsakorn Chuammitri; Chatchote Thitaram; Hathairat Thananchai; Teera Chewonarin; Korawan Sringarm; Kidsadagon Pringproa
Journal:  Animals (Basel)       Date:  2020-12-07       Impact factor: 2.752

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.